NCT05702229 2026-03-18
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
AstraZeneca
Phase 2 Recruiting
AstraZeneca
Bristol-Myers Squibb
Centre Leon Berard
GERCOR - Multidisciplinary Oncology Cooperative Group